TWENTE study: The real-world endeavor resolute versus xience v drug-eluting stent study in Twente: Study design, rationale and objectives

M.W.Z. Basalus; K. Tandjung; K.G. van Houwelingen; M.G. Stoel; F.H.A.F. de Man; J.W. Louwerenburg; S.A.M. Saïd; G.C.M. Linssen; M.A.W.J. Kleijne; J. van der Palen; J. Huisman; P.M.J. Verhorst; C. von Birgelen

doi:10.1007/BF03091792

TWENTE study: The real-world endeavor resolute versus xience v drug-eluting stent study in Twente: Study design, rationale and objectives

M.W.Z. Basalus, K. Tandjung, K.G. van Houwelingen, M.G. Stoel, F.H.A.F. de Man, J.W. Louwerenburg, S.A.M. Saïd, G.C.M. Linssen, M.A.W.J. Kleijne, J. van der Palen, J. Huisman, P.M.J. Verhorst, C. von Birgelen

Nanobiophysics

Research output: Contribution to journal › Article › Academic

10 Citations (Scopus)

Abstract

Background: New-generation drug-eluting stents (DES) may solve several problems encountered with first-generation DES, but there is a lack of prospective head-to-head comparisons between new-generation DES. In addition, the outcome of regulatory trials may not perfectly reflect the outcome in ‘real world’ patients.

Objectives: To compare the efficacy and safety of two new-generation DES in a ‘real world’ patient population.

Methods: A prospective, randomised, single-blinded clinical trial to evaluate clinical outcome after Endeavor Resolute vs. Xience V stent implantation. The primary endpoint is target vessel failure at one-year follow-up. In addition, the study comprises a two-year and an open-label five-year follow-up.

Original language	English
Pages (from-to)	360-364
Journal	Netherlands heart journal
Volume	18
Issue number	7-8
DOIs	https://doi.org/10.1007/BF03091792
Publication status	Published - 2010

Keywords

METIS-272829

Access to Document

10.1007/BF03091792

Cite this

Basalus, M. W. Z., Tandjung, K., van Houwelingen, K. G., Stoel, M. G., de Man, F. H. A. F., Louwerenburg, J. W., Saïd, S. A. M., Linssen, G. C. M., Kleijne, M. A. W. J., van der Palen, J., Huisman, J., Verhorst, P. M. J., & von Birgelen, C. (2010). TWENTE study: The real-world endeavor resolute versus xience v drug-eluting stent study in Twente: Study design, rationale and objectives. Netherlands heart journal, 18(7-8), 360-364. https://doi.org/10.1007/BF03091792

@article{e1901a8e79a4433ba017d5fb6e5cc94f,

title = "TWENTE study: The real-world endeavor resolute versus xience v drug-eluting stent study in Twente: Study design, rationale and objectives",

abstract = "Background: New-generation drug-eluting stents (DES) may solve several problems encountered with first-generation DES, but there is a lack of prospective head-to-head comparisons between new-generation DES. In addition, the outcome of regulatory trials may not perfectly reflect the outcome in {\textquoteleft}real world{\textquoteright} patients.Objectives: To compare the efficacy and safety of two new-generation DES in a {\textquoteleft}real world{\textquoteright} patient population.Methods: A prospective, randomised, single-blinded clinical trial to evaluate clinical outcome after Endeavor Resolute vs. Xience V stent implantation. The primary endpoint is target vessel failure at one-year follow-up. In addition, the study comprises a two-year and an open-label five-year follow-up.",

keywords = "METIS-272829",

author = "M.W.Z. Basalus and K. Tandjung and {van Houwelingen}, K.G. and M.G. Stoel and {de Man}, F.H.A.F. and J.W. Louwerenburg and S.A.M. Sa{\"i}d and G.C.M. Linssen and M.A.W.J. Kleijne and {van der Palen}, J. and J. Huisman and P.M.J. Verhorst and {von Birgelen}, C.",

year = "2010",

doi = "10.1007/BF03091792",

language = "English",

volume = "18",

pages = "360--364",

journal = "Netherlands heart journal",

issn = "1568-5888",

publisher = "Bohn Stafleu Van Loghum",

number = "7-8",

}

Basalus, MWZ, Tandjung, K, van Houwelingen, KG, Stoel, MG, de Man, FHAF, Louwerenburg, JW, Saïd, SAM, Linssen, GCM, Kleijne, MAWJ, van der Palen, J, Huisman, J, Verhorst, PMJ & von Birgelen, C 2010, 'TWENTE study: The real-world endeavor resolute versus xience v drug-eluting stent study in Twente: Study design, rationale and objectives', Netherlands heart journal, vol. 18, no. 7-8, pp. 360-364. https://doi.org/10.1007/BF03091792

TY - JOUR

T1 - TWENTE study: The real-world endeavor resolute versus xience v drug-eluting stent study in Twente

T2 - Study design, rationale and objectives

AU - Basalus, M.W.Z.

AU - Tandjung, K.

AU - van Houwelingen, K.G.

AU - Stoel, M.G.

AU - de Man, F.H.A.F.

AU - Louwerenburg, J.W.

AU - Saïd, S.A.M.

AU - Linssen, G.C.M.

AU - Kleijne, M.A.W.J.

AU - van der Palen, J.

AU - Huisman, J.

AU - Verhorst, P.M.J.

AU - von Birgelen, C.

PY - 2010

Y1 - 2010

N2 - Background: New-generation drug-eluting stents (DES) may solve several problems encountered with first-generation DES, but there is a lack of prospective head-to-head comparisons between new-generation DES. In addition, the outcome of regulatory trials may not perfectly reflect the outcome in ‘real world’ patients.Objectives: To compare the efficacy and safety of two new-generation DES in a ‘real world’ patient population.Methods: A prospective, randomised, single-blinded clinical trial to evaluate clinical outcome after Endeavor Resolute vs. Xience V stent implantation. The primary endpoint is target vessel failure at one-year follow-up. In addition, the study comprises a two-year and an open-label five-year follow-up.

AB - Background: New-generation drug-eluting stents (DES) may solve several problems encountered with first-generation DES, but there is a lack of prospective head-to-head comparisons between new-generation DES. In addition, the outcome of regulatory trials may not perfectly reflect the outcome in ‘real world’ patients.Objectives: To compare the efficacy and safety of two new-generation DES in a ‘real world’ patient population.Methods: A prospective, randomised, single-blinded clinical trial to evaluate clinical outcome after Endeavor Resolute vs. Xience V stent implantation. The primary endpoint is target vessel failure at one-year follow-up. In addition, the study comprises a two-year and an open-label five-year follow-up.

KW - METIS-272829

U2 - 10.1007/BF03091792

DO - 10.1007/BF03091792

M3 - Article

VL - 18

SP - 360

EP - 364

JO - Netherlands heart journal

JF - Netherlands heart journal

SN - 1568-5888

IS - 7-8

ER -

TWENTE study: The real-world endeavor resolute versus xience v drug-eluting stent study in Twente: Study design, rationale and objectives

Abstract

Keywords

Access to Document

Fingerprint

Cite this